Upcoming Abcam Webinar: MicroRNAs as biomarkers and therapeutic targets negative breast cancer

Upcoming Live Webinar and Q&A Session with Dr Brian D. Adams of Harvard Medical School and sponsorde by Abcam:

“MicroRNAs as biomarkers and therapeutic targets in triple negative breast cancer”

January 21, 2016 | 11:00am EST/ 8:00am PST

Register here

Triple negative breast cancer accounts for a disproportionate share of the total breast cancer morbidity because of its aggressive behavior, increased incidence in younger women, and lack of effective targeted therapies. miRNAs could serve as superior therapeutic agents for this breast cancer type.

This webinar will review:

  • miRNAs and noncoding RNA biology
  • Dysregulation of miRNAs associates with disease etiology
  • miRNAs as biomarkers
  • Techniques used to profile and study miRNA biology
  • miRNAs as therapeutic agents and/or targets

Can’t attend the live webinar? Don’t worry! Simply register today and receive the on-demand recording in your inbox within 24 hours of the live event.

About the Speaker:

Brian D. Adams, PhDBrian D. Adams is currently an Instructor at Harvard Medical School in the lab of Dr Frank Slack with over 9 years of experience in the fields of microRNA and cancer research. Brian completed his graduate studies at the University of Connecticut, where he was the first to identify that miRNAs are a crucial regulator of hormone-responsiveness in breast cancer patients. He further completed his postdoctoral studies at Yale, where he investigated how miRNAs can serve as chemo-sensitizers in the context of normal hematopoietic recovery and acute myeloid leukemia.

Subscribe to the miRNA blog

Thank you for subscribing.

Something went wrong.

Related Posts

Add Comment